This is a summary. To read the whole story subscribe to BostonGlobe.com
CVS Caremark shares outpaced the market after the drugstore chain raised its earnings forecast and reassured investors its business can absorb the hit from last week’s decision to stop selling tobacco: a $2 billion annual revenue loss and earnings 6 to 9 cents lower per share this year. CVS said fourth-quarter earnings climbed more than 12 percent to $1.27 billion, or $1.05 per share. Revenue rose nearly 5 percent to $32.83 billion. CVS raised its forecast for first-quarter earnings to $1.03 to $1.06 per share, up from 96 to 99 cents.